Cellular Therapy
Feature
Women hematologists advance MM research, give back
At the frontiers of CAR T-cell research for myeloma, women blood cancer specialists break new ground while also coaching their younger women...
Conference Coverage
CAR-T hikes overall survival in relapsed/refractory LBCL
Investigators say axi-cel should become the standard of care for second-line large B-cell lymphoma.
Conference Coverage
`Remarkable’: CAR T therapy for CLL/SLL
Primary analysis of the TRANSCEND CLL 004 trial showed that a single dose of CAR T therapy achieved durable responses in CLL and SLL, with a...
News
FDA approves new indication for avapritinib
Purported “first and only approved medicine” to treat adults with indolent systemic mastocytosis has been greenlit by the FDA.
News
FDA OKs stem cell therapy for blood cancer patients to reduce infection risks
Stem cell therapy approved by FDA for blood cancer patients aged 12 and older is aimed at reducing the risk of infections.
From the Journals
Venetoclax shows promise for r/r hairy cell leukemia
Italian study suggests benefits of administering venetoclax for patients with r/r cases of hairy cell leukemia, a rare blood cancer,
Feature
Inclusive reminder: LGBTQ community may donate stem cells
Advocates seek to reach donors who wrongly assumed that they were restricted from joining registries.
Feature
High cost and demand for old cancer drug sparks crisis
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
From the Journals
Gloom lifting as MCL treatments evolve
A rare blood cancer remains incurable, yet new therapies have yielded improved prognoses and survival rates.
From the Journals
CAR T-cell therapy neurotoxicity linked to NfL elevations
Even prior to CAR T-cell therapy, patients developing related neurotoxic complications show elevated markers of neuronal injury.
From the Journals
Novel approach brings hospice-bound MM patient into remission
With the use of next-generation genomic sequencing and a novel triple therapy, a patient who had relapsed after CAR T-cell therapy was brought...